Sevoflurane Liquid
Product Images NDC 42677-308

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Sevoflurane (NDC 42677-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong New Time Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-lable (Carton Lable)

Carton label for Sevoflurane USP 250 mL liquid inhalation anesthetic. The label includes the NDC 42677-308-01, usage instructions, storage conditions (15° to 30°C), and manufacturer Shandong New Time Pharmaceutical Co., Ltd. It displays the product name prominently in yellow boxes and notes that it is prescription only (Rx only).*

FDA Label Image

Container-lable (Container Lable)

Label for Sevoflurane USP 250 mL, a liquid inhalation anesthetic. It includes the product name, strength, and the labeler Shandong New Time Pharmaceutical Co., Ltd. The label also states it is for prescription use only (Rx only), contains storage instructions, and a barcode.*

FDA Label Image

Figure1- (Figure1)

A line graph depicting the relationship between fresh gas flow rate in liters per minute (x-axis) and concentration of Compound A in parts per million (ppm) (y-axis). The graph shows data points at flow rates from 0.5 to 4 L/min, with Compound A concentration decreasing as flow rate increases, leveling off around the higher flow rates.*

FDA Label Image

Figure10- (Figure10)

A line graph depicting flow rate in liters per minute per square meter (L/min/m²) on the vertical axis versus MAC level on the horizontal axis. Two series are plotted: one for Sevoflurane with oxygen (Sevo/O₂) marked by diamonds, and one for Sevoflurane with oxygen and nitrous oxide (Sevo/O₂/N₂O) marked by triangles, showing values at baseline and various MAC levels from 1 to 2.*

FDA Label Image

Figure2- (Figure2)

A line chart plotting Compound A concentration in ppm and maximum temperature in degrees Celsius against carbon dioxide flow in mL/min. The chart has two lines: one with circles representing Compound A levels, which increase as carbon dioxide flow increases, and another with squares representing maximum temperature, also rising with increasing carbon dioxide flow.*

FDA Label Image

Figure2a- (Figure2a)

A scatter plot with a regression line showing the correlation between Sevoflurane exposure (MAC-Hour) on the x-axis and Inspired Compound A AUC (ppm-hr) on the y-axis. Data points are distributed along the line indicating a strong positive correlation with r = 0.96 and p < 0.001.*

FDA Label Image

Figure3-- (Figure3)

A line graph depicting the ratio FA/FI on the y-axis versus minutes of administration on the x-axis, showing different inhalation agents including Halothane, Isoflurane, Sevoflurane, Desflurane, and N2O (Nitrous Oxide). The graph compares the uptake or concentration curves of these agents over a 30-minute administration period.*

FDA Label Image

Figure4- (Figure4)

A line graph comparing elimination rates of five anesthetic agents (Halothane, Isoflurane, Sevoflurane, Desflurane, and Nitrous Oxide) over time. The x-axis represents minutes of elimination up to 120 minutes, and the y-axis shows the fraction remaining on a logarithmic scale from 0.001 to 1. Sevoflurane is represented by filled circles among the plotted agents.*

FDA Label Image

Figure5- (Figure5)

A line graph depicting serum fluoride levels (µM) over days post-anesthesia for six anesthetics: Methoxyflurane, Sevoflurane, Enflurane, Isoflurane, and Halothane. The x-axis ranges from pre-anesthesia to 6 days post-anesthesia, and the y-axis ranges from 0 to 70 µM serum fluoride. Sevoflurane shows a peak around day 1 then declines, while other anesthetics display lower levels.*

FDA Label Image

Figure6- (Figure6)

A pharmacokinetic curve graph showing concentration (µM) over time (hours) for Sevoflurane. The plot includes lines representing mean concentration and mean concentration plus one, two, and three standard deviations, illustrating variability in concentration over a 48-hour period.*

FDA Label Image

Figure7- (Figure7)

A line graph comparing heart rates in beats per minute (y-axis) at baseline and various MAC levels (x-axis) for Sevoflurane combined with oxygen (Sevo/O2) and Sevoflurane combined with oxygen and nitrous oxide (Sevo/O2/N2O). The graph includes error bars and distinct markers for each treatment group.*

FDA Label Image

Figure8- (Figure8)

A line graph comparing Sevoflurane administered with oxygen (Sevo/O2) and with oxygen/nitrous oxide mixture (Sevo/O2/N2O). The vertical axis measures mmHg (millimeters of mercury), and the horizontal axis shows MAC levels from baseline to 2.5. Data points with error bars indicate changes in mmHg at different MAC levels for both groups.*

FDA Label Image

Figure9- (Figure9)

A line graph comparing measurements labeled as 'A - Sevo/O2' and 'C - Sevo/O2/N2O' plotted against MAC level on the x-axis and dyne·sec·cm⁻⁵ on the y-axis. The graph shows baseline values and data points at various MAC levels with error bars, illustrating trends in dyne·sec·cm⁻⁵ for each condition.*

FDA Label Image

Structure0- (Structure0)

Chemical structure diagram of Sevoflurane showing the arrangement of carbon, hydrogen, fluorine, and oxygen atoms typical for the anesthetic agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.